Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

2.

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

3.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

4.

PSMA PET Beats MRI in Prostate Cancer Staging Study

5.

Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot